Keller AR - Search Results

1

Mitigating Pediatric Inpatient Aggression: A Quality Improvement Initiative.

Keller AR, Kanaley RL, Starr T, Strollo B, Scharf M, Massachi S, Angell L, Clough CD, Schriefer J. Keller AR, et al. Hosp Pediatr. 2022 May 1;12(5):499-506. doi: 10.1542/hpeds.2021-006431. Hosp Pediatr. 2022. PMID: 35476133

2

Improving Employee Safety Through a Comprehensive Patient Behavioral Program.

Laprime A, Kanaley R, Keller A, Stephen SJ, Schriefer J, Fallon A, Sosa T. Laprime A, et al. Hosp Pediatr. 2024 May 1;14(5):356-363. doi: 10.1542/hpeds.2023-007714. Hosp Pediatr. 2024. PMID: 38606483

3

Molecular imaging in experimental pulmonary fibrosis reveals that nintedanib unexpectedly modulates CCR2 immune cell infiltration.

Farooq H, Luehmann HP, Koenitzer JR, Heo GS, Sultan DH, Kulkarni DH, Gunsten SP, Sashti RM, Huang T, Keller AR, Lavine KJ, Atkinson JJ, Wingler LM, Liu Y, Brody SL. Farooq H, et al. Among authors: keller ar. EBioMedicine. 2024 Dec;110:105431. doi: 10.1016/j.ebiom.2024.105431. Epub 2024 Nov 7. EBioMedicine. 2024. PMID: 39515027 Free PMC article.

4

Molecular consequences of SCA5 mutations in the spectrin-repeat domains of β-III-spectrin.

Denha SA, DeLaet NR, Abukamil AW, Alexopoulos AN, Keller AR, Atang AE, Avery AW. Denha SA, et al. Among authors: keller ar. bioRxiv [Preprint]. 2024 Sep 19:2024.09.17.613313. doi: 10.1101/2024.09.17.613313. bioRxiv. 2024. PMID: 39345584 Free PMC article. Preprint.

5

Nanobody-Mediated Dualsteric Engagement of the Angiotensin Receptor Broadens Biased Ligand Pharmacology.

Braga Emidio N, Small BM, Keller AR, Cheloha RW, Wingler LM. Braga Emidio N, et al. Among authors: keller ar. Mol Pharmacol. 2024 Feb 15;105(3):260-271. doi: 10.1124/molpharm.123.000797. Mol Pharmacol. 2024. PMID: 38164609 Free PMC article.

6

Increased Actin Binding Is a Shared Molecular Consequence of Numerous SCA5 Mutations in β-III-Spectrin.

Atang AE, Keller AR, Denha SA, Avery AW. Atang AE, et al. Among authors: keller ar. Cells. 2023 Aug 19;12(16):2100. doi: 10.3390/cells12162100. Cells. 2023. PMID: 37626910 Free PMC article.

7

Increased actin binding is a shared molecular consequence of numerous spinocerebellar ataxia mutations in β-III-spectrin.

Atang AE, Keller AR, Denha SA, Avery AW. Atang AE, et al. Among authors: keller ar. bioRxiv [Preprint]. 2023 Apr 10:2023.02.20.529285. doi: 10.1101/2023.02.20.529285. bioRxiv. 2023. Update in: Cells. 2023 Aug 19;12(16):2100. doi: 10.3390/cells12162100 PMID: 36865188 Free PMC article. Updated. Preprint.

8

Early-phase drug discovery of β-III-spectrin actin-binding modulators for treatment of spinocerebellar ataxia type 5.

Guhathakurta P, Rebbeck RT, Denha SA, Keller AR, Carter AL, Atang AE, Svensson B, Thomas DD, Hays TS, Avery AW. Guhathakurta P, et al. Among authors: keller ar. J Biol Chem. 2023 Mar;299(3):102956. doi: 10.1016/j.jbc.2023.102956. Epub 2023 Jan 31. J Biol Chem. 2023. PMID: 36731793 Free PMC article.

9

Hodgkin's disease of the thymus gland.

Keller AR, Castleman B. Keller AR, et al. Cancer. 1974 Jun;33(6):1615-23. doi: 10.1002/1097-0142(197406)33:6<1615::aid-cncr2820330622>3.0.co;2-u. Cancer. 1974. PMID: 4834156 No abstract available.

10

Hodgkin's disease of the lung.

Whitcomb ME, Schwarz MI, Keller AR, Flannery EP, Blom J. Whitcomb ME, et al. Among authors: keller ar. Am Rev Respir Dis. 1972 Jul;106(1):79-85. doi: 10.1164/arrd.1972.106.1.79. Am Rev Respir Dis. 1972. PMID: 5036834 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters